Contract W9113M09P0009
Emergent Biodefense Operations Lansing Llc · Department Of Defense · January 16, 2009
Emergent Biodefense Operations Lansing Llc was awarded a federal contract by Department Of Defense (Department Of The Army) on January 16, 2009 for $65,000 of work in biological product (except diagnostic) manufacturing. Performance is in Lansing, MI. It was awarded under full and open competition. The contract has been modified 1 time since the base award It uses firm fixed-price contract pricing. The most recent modification was on March 20, 2009.
Contract details
- PIID
- W9113M09P0009
- Award type
- Purchase Order
- Pricing
- Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Not Competed
- NAICS
- 325414 · Biological Product (Except Diagnostic) Manufacturing
- Product / service
- Laboratory Testing Services
- Place of performance
- Lansing, MI
- First action
- January 16, 2009
- Latest action
- March 20, 2009
Description
FY09 PBT TESTING
Modification timeline
-
March 20, 2009Mod P00001$0
-
January 16, 2009Base award$65.1K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Greer Laboratories, Inc. | Department Of Defense | December 19, 2025 | $470.4K |
| Greer Laboratories, Inc. | Department Of Defense | December 18, 2025 | $0 |
| Lifestream Blood Bank | Department Of Defense | December 18, 2025 | $29.7K |
| Kemp Proteins, Llc | Department Of Defense | December 18, 2025 | $40.0K |
| Applied Dna Sciences, Inc. | Department Of Defense | December 15, 2025 | $1 |
| Sanofi Vaccines Us Inc. | Department Of Defense | December 12, 2025 | $486.7K |
Top contractors in NAICS 325414
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Pfizer Inc | 3 | $15.27B |
| 2 | Sanofi Vaccines Us Inc. | 606 | $9.38B |
| 3 | Regeneron Pharmaceuticals Inc | 1 | $5.57B |
| 4 | Merck Sharp & Dohme Corp. | 56 | $3.99B |
| 5 | Emergent Biodefense Operations Lansing Llc | 16 | $3.34B |
| 6 | Merck Sharp & Dohme Llc | 15 | $3.33B |
| 7 | Pfizer Inc. | 25 | $3.11B |
| 8 | Glaxosmithkline Holdings (Americas) Inc. | 109 | $2.24B |
| 9 | Modernatx, Inc. | 1 | $1.75B |
| 10 | Bavarian Nordic A/S | 1 | $1.01B |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract W9113M09P0009?
Contract W9113M09P0009 is a federal contract awarded to Emergent Biodefense Operations Lansing Llc by Department Of Defense on January 16, 2009 for $65,000 of work classified under BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING. It has been modified 1 time since the base award.
Who won contract W9113M09P0009?
Emergent Biodefense Operations Lansing Llc won contract W9113M09P0009 from Department Of Defense.
How much is contract W9113M09P0009 worth?
Contract W9113M09P0009 has obligated $65,000 to date.